AGREEMENTRegistrar Agreement Agreement • February 1st, 2008 • Plata Resources, Inc.
This agreement made and entered into the 20th day of July, 2007, by and between Action Stock Transfer Corporation hereinafter referred to as Action and Plata Resources, Inc. hereinafter referred to as the Company.
LEASE AGREEMENT BY AND BETWEEN HILLSIDE SQUARE LLC, LESSOR, -and- NEXUS BIOPHARMA INC., LESSEE LEASED PREMISES: HILLSIDE SQUARE SUITE 108 MONTCLAIR, NEW JERSEY 07042Lease Agreement • September 2nd, 2016 • Nexus Biopharma Inc • Pharmaceutical preparations
THIS LEASE AGREEMENT is made this 22nd day of July, 2016 by and between HILLSIDE SQUARE LLC, a New Jersey limited liability company (“Lessor”) whose address is c/o The Bravitas Group, 105 Grove Street, Montclair, New Jersey 07042, and NEXUS BIOPHARMA INC., a corporation (“Lessee”) with offices located at 8 Hillside Avenue, Suite 108, Montclair, New Jersey 07042.
ContractNexus Biopharma Inc • November 4th, 2016 • Pharmaceutical preparations • New York
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO BORROWER.
AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • May 19th, 2016 • Nexus Biopharma Inc • Metal mining • New York
This Agreement and Plan of Reorganization, is made and entered into as of May 17, 2016, (this “Agreement”) by and among Nexus BioPharma, Inc., a Nevada corporation (“Nexus”), with its principal executive office located at 2911 Park Avenue, Pasay City, Metro Manila, Philippines, and Nexus BioPharma Corporation, a Delaware corporation (“NBPC”), with its principal executive offices located at 8 Hillside Ave., Montclair, New Jersey 07042, and Nexus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Nexus with its office located at 2911 Park Avenue, Pasay City, Metro Manila, Philippines (“Acquisition Corp”). For purposes of this Agreement, Nexus, NBPC, and Acquisition Corp. are sometimes collectively referred to as the “Parties” and individually as a “Party.”
AMENDED AND RESTATED AGREEMENT AND PLAN OF REORGANIZATIONAnd Restated Agreement and Plan of Reorganization • June 15th, 2016 • Nexus Biopharma Inc • Metal mining • New York
This Amended and Restated Agreement and Plan of Reorganization, is made and entered into as of June 9, 2016, (this “Agreement”) by and among Nexus BioPharma, Inc., a Nevada corporation (“Nexus”), with its principal executive office located at 2911 Park Avenue, Pasay City, Metro Manila, Philippines, and Nexus BioPharma Inc., a Delaware corporation (“NBPC”), with its principal executive offices located at 8 Hillside Ave., Montclair, New Jersey 07042, and Nexus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Nexus with its office located at 2911 Park Avenue, Pasay City, Metro Manila, Philippines (“Acquisition Corp”). For purposes of this Agreement, Nexus, NBPC, and Acquisition Corp. are sometimes collectively referred to as the “Parties” and individually as a “Party.”
SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-03082017Securities Purchase Agreement • March 16th, 2017 • Nexus Biopharma Inc • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of March 8, 2017, between Nexus BioPharma, Inc., a Nevada corporation (the “Issuer”) and JMJ Financial (the “Investor”) (referred to collectively herein as the “Parties”).
AGREEMENT AND PLAN OF MERGER between PLATA RESOURCES, INC. (a Nevada corporation) and PLATA PRIME, INC. (a Nevada corporation)Agreement and Plan of Merger • May 18th, 2016 • Plata Resources, Inc. • Metal mining • Nevada
THIS AGREEMENT AND PLAN OF MERGER, dated as of April 22, 2016, between Plata Resources, Inc., a Nevada corporation (“Parent”), and Plata Prime, Inc., a Nevada corporation and a direct wholly owned subsidiary of Parent (“Merger Sub” and together with Parent the “Constituent Corporations”)
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • June 15th, 2016 • Nexus Biopharma Inc • Metal mining • England and Wales
BioFocus DPI Limited a company incorporated under the laws of England and Wales (under company registration number 4622227) whose registered address is at Charles River, Manston Road, Margate, Kent, CT9, United Kingdom and whose principal place of business is at Chesterford Research Park, Saffron Walden, Essex CB10 1XL, United Kingdom
